Scientists Thought These Protein Clumps Were Killing Brain Cells. They Might Be Saving Them.

Huntington’s Disease Researchers Find an Unlikely Ally Inside Dying Neurons

For decades, scientists assumed the protein clumps that form inside brain cells in Huntington’s disease were part of the problem. New research suggests they might actually be part of the solution, and one stress-response gene appears to be a key part of how those clumps form.

Huntington’s disease is a fatal brain disorder with no cure. It’s caused by a genetic mutation that forces the huntingtin protein to misfold and aggregate inside nerve cells, a process linked to the brain-cell damage that defines the disease. Those clumps, called inclusion bodies, have long been viewed with suspicion by researchers who thought they were a sign of cellular damage, like smoke from a fire already burning out of control. But a new study published in the journal Cell Death & Differentiation upends that assumption. Researchers found that, in human neurons, these clumps appear to actually protect cells from dying, and that a gene called ATF3 is essential to making them form.

Rather than relying on animal models or simple lab cell lines, the scientists built a human brain-cell system using stem cells derived from actual patients. That allowed them to watch neurons with clumps and neurons without clumps, growing side by side and genetically identical, respond differently to the same cellular stress. Cells with clumps survived at significantly higher rates.

Building a Human Model of Huntington’s Disease

Researchers at the Hebrew University of Jerusalem used induced pluripotent stem cells, adult cells reprogrammed to behave like early-development stem cells that can become nearly any cell in the body, including brain cells.

Two approaches were used. In one, the team took stem cells from a genetically corrected patient line and introduced a mutant version of the Huntington’s gene carrying 105 repetitions of a specific genetic stutter, well above the threshold of 39 repetitions that causes disease in humans. In the second, they used stem cells from a patient with 180 repetitions and tagged naturally occurring clumps with a glowing green marker. A specialized cell-sorting technique then allowed them to separate clump-containing cells from genetically identical clump-free neighbors growing in the same dish.

Watching Huntington’s Disease Cells Live and Die

With their model established, the team put the cells under stress using a drug called Tunicamycin, which jams the protein-folding process and triggers a cellular distress response. Using live video microscopy over roughly 30 hours, tracking more than 1,000 cells across multiple experiments, they found that cells with clumps died at significantly lower rates than their clump-free counterparts.

The ATF3 Gene Behind Protective Clump Formation

To understand why some cells form clumps and others don’t, researchers compared gene activity between the two populations. Across both cell systems and multiple independent experiments, one gene kept appearing at the top of the list: ATF3.

Analysis suggested ATF3 was regulating many of the other altered genes. To test whether it was necessary for clump formation, the team used the gene-editing tool CRISPR to delete ATF3. In this cell system, cells lacking ATF3 failed to form the clumps even after repeated enrichment attempts, and when exposed to the same stress test, they died at significantly higher rates. A version of ATF3 that was present but unable to bind DNA produced the same outcome, confirming that ATF3 needs direct DNA contact to do its job.

Further analysis showed ATF3 attaching to control regions of genes tied to the cell’s protein-folding stress response and to inflammation, including the gene that produces a signaling molecule called IL-8. IL-8 was secreted at more than eight times higher levels in clump-containing cells across both cell systems, and has been found at elevated levels in the brain tissue of deceased Huntington’s patients.

Why the Human Cell Model Changes the Picture

Beyond the petri dish, the team reanalyzed genetic data from the brain tissue of deceased Huntington’s patients. They found that 21 of the 37 genes more active in clump-containing cells were also altered in patient brain tissue, a level of overlap the authors describe as statistically highly significant.

Using human neurons rather than mouse models matters here. IL-8 is expressed in humans but not in mice, meaning it would have been invisible in animal-based studies. That also creates a practical challenge for follow-up research, since most available tools for studying IL-8’s role in the brain were built around mouse biology.

What the study leaves open is whether this short-term protection translates to years of disease progression in patients. Still, ATF3 and the stress-response pathways it controls are now worth serious attention as possible therapy targets for Huntington’s and other polyQ diseases caused by expanded CAG repeats, though much more work is needed before anyone knows whether they can be safely manipulated.

---

Disclaimer: This article is based on a peer-reviewed research study but is intended for general informational purposes only. It does not constitute medical advice. The findings described reflect results from a laboratory cell model and have not been tested in humans as a treatment or therapy.

---